ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2224

Tailored, Online Education on Comparative Effectiveness Studies in Rheumatoid Arthritis: Success in Improving Knowledge and Clinical Decisions

Nimish Mehta, Emilie McCardell and Kathleen Geissel, Medscape, LLC, New York, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Comparative effectiveness and harms, educational innovation, Outcome measures, rheumatoid arthritis (RA) and technology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Education Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Analysis of past educational activities on comparative effectiveness studies in RA identified different educational needs for varying segments of rheumatologists – from interpretation of clinical results to application in practice. A study was conducted to measure the effectiveness of using responses to a single-question as a method to segment the physician audience and to provide a tailored learning approach specific to the needs of each group.

Methods: We utilized a unique online, single-question segmentation using branching logic, in order to tailor education that rheumatologists needed most regarding comparative effectiveness studies in RA. Participants were presented with a single question that tested their interpretation of results from AMPLE and ADACTA. Those who answered correctly were directed to an educational activity on applying these results in case scenarios, and those who answered incorrectly were directed to an activity on interpretation of results. Once the participants were directed to a specific activity, online survey instruments using knowledge- and case-based, multiple-choice questions were administered to compare the same participants’ responses to 4 identical questions before and after each activity.  McNemar’s chi-squared test was used to determine statistical significance between responses. Cramer’s V was used to calculate the effect sizes of education, based on the strength of association between the pre-assessment and post-assessment responses. The activities launched in December 2014 – January 2015, and data were collected through March, 2015.

Results: In total, 112 rheumatologist responses were analyzed in this study. Tailoring education designed to match individual deficiencies in knowledge and skills of rheumatologists to specific educational activities on comparative effectiveness in RA resulted in robust educational effect (effect sizes ranging from V = 0.038 to 0.134 across 4 activities, P < .001). Analysis of the effect of education on specific learning goals showed:

  • 52% increase in the decision to add abatacept in a patient with inadequate response to MTX, based on data from AMPLE study (P < .001)

  • 56% increase in the selection of tocilizumab based on results from ADACTA trial, in a patient who discontinued MTX due to intolerance and progressed to a DAS28 of 6.5 (P < .001)

  • More than 38% improvement in identifying patient populations and dosage of biologics studied in ADACTA trial (P < .05)

  • 28% improvement in the interpretation of results of AMPLE trial (P = .057)

Conclusion: Large, statistically significant improvements in knowledge and competence of rheumatologists regarding comparative effectiveness studies in RA demonstrated the success of using online branching logic to segment the participants and providing education on topic areas they needed the most. Recognizing that rheumatologists are at various stages of understanding and skills in application of clinical trial data from various landmark studies, this approach may be used to maximize translation of data into clinical decisions.


Disclosure: N. Mehta, None; E. McCardell, None; K. Geissel, None.

To cite this abstract in AMA style:

Mehta N, McCardell E, Geissel K. Tailored, Online Education on Comparative Effectiveness Studies in Rheumatoid Arthritis: Success in Improving Knowledge and Clinical Decisions [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/tailored-online-education-on-comparative-effectiveness-studies-in-rheumatoid-arthritis-success-in-improving-knowledge-and-clinical-decisions/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tailored-online-education-on-comparative-effectiveness-studies-in-rheumatoid-arthritis-success-in-improving-knowledge-and-clinical-decisions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology